SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Abraham Lincoln Synthetic CCD
| Patient | Abraham Lincoln |
|---|
| Date of birth | 1994-02-12 |
|---|
| Identifiers | MRN HR-NI001-SYN; SSN (made up) 000-01-6683 |
|---|
| Document date | 2026-11-01 |
|---|
| Author | Elena Marquez, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Visit
Primary care visit for low mood and sleep disturbance. Concerns: Low mood, loss of interest, and poor sleep are affecting legal work and friendships. [S]
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Sertraline 50 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-06-30 | active | S |
| Prednisone 20 mg oral tablet, tapering course: three tablets each morning for 5 days, two for 5 days, then one for 5 days | Each morning with breakfast: 60 mg for 5 days, 40 mg for 5 days, then 20 mg for 5 days | Oral route | 2026-10-09 to 2026-10-23 | completed | S |
Immunizations
| Date | Vaccine | Status | Evidence |
|---|
| 2022-04-11 | Tdap vaccine | completed | S |
| 2025-10-20 | Influenza vaccine, 2025-2026 season | completed | S |
| 2026-10-27 | Influenza vaccine, 2026-2027 season | completed | S |
Past Medical History
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|
| Tenth year (about 1818-1819) | Kicked by a horse in his tenth year and briefly appeared lifeless; no lasting injury is documented | D (CLM-0004) |
| January 23, 1841 | Severe low mood in January 1841, described in his own words as being "the most miserable man living" | D (CLM-0005) |
| Adult life | Recurrent melancholy retrospectively interpreted as chronic depression | R (CLM-0006) |
| Lifelong | Tall, slender build retrospectively proposed as Marfan syndrome or another inherited marfanoid disorder; disputed and never genetically confirmed | R (CLM-0008) |
Family History
| Relative | Condition | Age at death | Evidence |
|---|
| mother | Died of milk sickness (poisoning from milk of cows that ate white snakeroot) in 1818 | | D (CLM-0007) |
| sister | Died from complications during delivery in 1828 | 21 | D (CLM-0009) |
Health Concerns
| Concern | Status | Evidence |
|---|
| Low mood, loss of interest, and poor sleep are affecting legal work and friendships | active | S |
Assessment
- Major depressive disorder, single episode, moderate; synthetic modern diagnosis linked to documented low mood and its retrospective interpretation: active, provisional [S]
- Allergic contact dermatitis from poison ivy, extensive, resolved with a tapering course of prednisone: resolved, confirmed [S]
Most recent measures: Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 2026-10-27; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 2 on 2026-10-27; Total score [AUDIT-C] 0 on 2026-10-27 [S]
Strengths and supports: Supports: close friend and law colleagues; values correspondence and storytelling [S]
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Major depressive disorder, single episode, moderate; synthetic modern diagnosis linked to documented low mood and its retrospective interpretation | active | provisional |
F32.1 | S — Synthetic active diagnosis for the teaching episode; the historical depression label remains R. |
| Allergic contact dermatitis from poison ivy, extensive, resolved with a tapering course of prednisone | resolved | confirmed |
L23.7 | S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness. |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-06-30 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 14 | {score} | | | S |
| 2026-08-11 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | {score} | | | S |
| 2026-09-30 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | | | S |
| 2026-10-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | | | S |
| 2026-10-27 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 2 | {score} | | | S |
| 2026-10-27 | Total score [AUDIT-C] | 0 | {score} | | | S |
Social History
- Current tobacco use: none reported [S]
- Current alcohol use: none reported [S]
- Occupation: attorney with public-service commitments [S]
- Supports: close friend and law colleagues; values correspondence and storytelling [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 2026-06-30 | Body height | 193 | cm | S |
| 2026-06-30 | Body weight | 82 | kg | S |
| 2026-06-30 | Body mass index (BMI) [Ratio] | 22 | kg/m2 | S |
| 2026-06-30 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-06-30 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-06-30 | Heart rate | 74 | /min | S |
| 2026-06-30 | Respiratory rate | 14 | /min | S |
| 2026-06-30 | Body temperature | 36.7 | Cel | S |
| 2026-06-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-08-11 | Body height | 193 | cm | S |
| 2026-08-11 | Body weight | 82.4 | kg | S |
| 2026-08-11 | Body mass index (BMI) [Ratio] | 22.1 | kg/m2 | S |
| 2026-08-11 | Systolic blood pressure | 116 | mm[Hg] | S |
| 2026-08-11 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-08-11 | Heart rate | 70 | /min | S |
| 2026-08-11 | Respiratory rate | 14 | /min | S |
| 2026-08-11 | Body temperature | 36.8 | Cel | S |
| 2026-08-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-09-30 | Body height | 193 | cm | S |
| 2026-09-30 | Body weight | 83 | kg | S |
| 2026-09-30 | Body mass index (BMI) [Ratio] | 22.3 | kg/m2 | S |
| 2026-09-30 | Systolic blood pressure | 114 | mm[Hg] | S |
| 2026-09-30 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-09-30 | Heart rate | 66 | /min | S |
| 2026-09-30 | Respiratory rate | 14 | /min | S |
| 2026-09-30 | Body temperature | 36.7 | Cel | S |
| 2026-09-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-10-09 | Body height | 193 | cm | S |
| 2026-10-09 | Body weight | 83.2 | kg | S |
| 2026-10-09 | Body mass index (BMI) [Ratio] | 22.3 | kg/m2 | S |
| 2026-10-09 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-10-09 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-10-09 | Heart rate | 72 | /min | S |
| 2026-10-09 | Respiratory rate | 14 | /min | S |
| 2026-10-09 | Body temperature | 36.8 | Cel | S |
| 2026-10-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 2026-10-27 | Body height | 193 | cm | S |
| 2026-10-27 | Body weight | 83.4 | kg | S |
| 2026-10-27 | Body mass index (BMI) [Ratio] | 22.4 | kg/m2 | S |
| 2026-10-27 | Systolic blood pressure | 116 | mm[Hg] | S |
| 2026-10-27 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-10-27 | Heart rate | 64 | /min | S |
| 2026-10-27 | Respiratory rate | 14 | /min | S |
| 2026-10-27 | Body temperature | 36.6 | Cel | S |
| 2026-10-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Encounters
| Date | Purpose | Status | Provenance |
| 2026-06-30 | Primary care visit for low mood and sleep disturbance | finished | S |
| 2026-08-11 | Six-week depression treatment follow-up | finished | S |
| 2026-09-30 | Twelve-week depression care-plan review | finished | S |
| 2026-10-09 | Same-day sick visit for a poison ivy rash | finished | S |
| 2026-10-27 | Adult preventive visit | finished | S |
Plan of Treatment
| Intervention | Status | Guideline | Provenance |
| Use shared decision-making to choose monotherapy for uncomplicated major depression; patient prefers medication over psychotherapy | completed | GL-MDD-2022 | S |
| Start sertraline 50 mg daily; review expected time to benefit, common adverse effects, and how to reach the clinic | completed | GL-MDD-2022 | S |
| Repeat PHQ-9 at six and twelve weeks and adjust treatment if response is inadequate; plan continuation treatment after remission | completed | GL-MDD-2022 | S |
| Create a collaborative safety plan with crisis resources, including the 988 Suicide & Crisis Lifeline | completed | GL-SUICIDE-2024 | S |
| Psychiatry consultation to confirm the diagnosis and advise on medication management | completed | GL-MDD-2022 | S |
Goals
| Goal | Target | Status | Outcome | Provenance |
| Reduce PHQ-9 score from 14 to below 5 by the twelve-week review | 2026-09-30 | completed | PHQ-9 score 4 | S |
| Take sertraline as prescribed on at least six of seven days each week | 2026-09-30 | completed | Taken on most days; mild nausea resolved by week three | S |
| Resume at least two valued activities each week, such as court work and letters to friends | 2026-08-11 | completed | Resumed by the six-week visit | S |
Functional Status
- Independent in basic and instrumental activities of daily living [S]
- Low mood and poor sleep reduce concentration and work attendance [S]
Mental Status
- Alert and fully oriented; reflective and articulate [S]
- Depressed mood with constricted affect at intake [S]
- Thought process linear; no psychotic features; insight and judgment good [S]
Structured synthetic safety assessment on 2026-06-30: current ideation absent, intent absent, plan absent. Outpatient care with a collaborative safety plan, crisis resources, and scheduled follow-up [S]